Vitekta FDA Approval History
FDA Approved: Yes (Discontinued) (First approved September 24, 2014)
Brand name: Vitekta
Generic name: elvitegravir
Dosage form: Tablets
Company: Gilead Sciences, Inc.
Treatment for: HIV Infection
Marketing Status: Discontinued
Vitekta (elvitegravir) is an integrase inhibitor for the combination treatment of HIV-1 infection in treatment-experienced adults.
Development timeline for Vitekta
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.